Chris Hamman is the Director of Training at Genentech, currently leading a team focused on hemophilia A, spinal muscle atrophy, and Alzheimer's Disease. With over ten years of experience in the biotech market, Chris has previously held roles such as Senior Clinical Trainer and Senior Training Manager at Genentech, along with positions in research and market analysis. Chris earned a BS in Chemistry from the University of Richmond and an MS in Chemistry from Northeastern University, contributing both scientific and strategic insights to the industry.
Location
San Francisco, United States